Kymera Therapeutics, Inc.

Q4 2021 13F Holders

Symbol
KYMR
CUSIP
501575104
Type
Equity
Class
COM
Num filers
131
Total reported value, excl. options
$2.76B
Manager Report Date Value ($000) Shares